Pillstats
Rx only · Solution · Ophthalmic

Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2551
US makers2 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.533$1.07$1.60$2.13Dec 2025Apr 2026Jul 2026
$1.784
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Advagen Pharma Ltdunknown3SUPPLYING
Altaire Pharmaceuticals Inc.unknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 2, 2019
    RECALLRecall (Class II): Altaire Ciprofloxacin HCl Ophthalmic Solution, 0.3%, 5 mL, NDC 59390-217-05

    Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide

  • Jul 2, 2019
    RECALLRecall (Class II): Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, 10 mL, Rx only, Altaire Pharmaceuticals, Inc. Aquebogue, NY 119…

    Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide

  • Jul 2, 2019
    RECALLRecall (Class II): Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 …

    Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide